Arakis Ltd v Media Pharma GmbH & Co KG

Link copied
Case Copied 38 min read

ABSTRACTS OF DECISIONS

DECISION OF A DELEGATE OF THE COMMISSIONER OF PATENTS

Application  :          No. 776913 in the name of ARAKIS LTD

Title:          The treatment of respiratory diseases

Action: Opposition under section 59 of the Patents Act by MEDA PHARMA GMBH & CO KG, compliance with a notice requiring production of certain documents, and objections to extensions of time to serve evidence in reply and a direction to defer service of evidence in reply until the notice to produce has been finally dealt with

Decision:          Issued 16 December 2008.

Abstract

A notice requiring the production of certain documents relating to a clinical trial on which the evidence in answer was based was served on the applicant.

The applicant claimed lawful excuse for not producing the documents covered by the notice for the reasons that (1) the Commissioner did not have jurisdiction to issue the notice as the applicant was located overseas, (2) the documents in question were not in their possession or control due to contractual obligations owed to a third party and (3) the documents were not relevant to the opposition.  The opponent nevertheless pressed for compliance with the notice to produce.

The opponent for their part argued that they were unable to properly respond to the evidence in answer until they were granted access to the documents sought by them or the fate of the notice to produce was otherwise decided.  The opponent consequently requested that the time for serving evidence in reply be extended under regulation 5.10(2), or a direction be issued under regulation 5.10(1), to suspend the service of evidence in reply until the applicant’s non-compliance with the notice to produce had been resolved.  The applicant objected to both requests.

All matters were heard concurrently.  Found:

  • The questions of whether the Commissioner has extra-territorial jurisdiction to issue notices requiring production on persons located outside of the area delineated by section 12 of the Act, and whether the documents sought by the opponent were in the possession or control of the applicant, ultimately did not need to be decided;
  • The documents sought by the opponent are not relevant to the opposition;
  • The total extension sought by the opponent, although appropriate in all the circumstances, would not allow them any time to respond to the evidence in answer which would not be in the public interest in having the opposition decided on its merits.  A direction to defer the service of evidence in reply for a specified time was accordingly issued which would also have the effect of regulating the progress of the opposition; and 
  • Although a variation of costs was unwarranted, costs were awarded under schedule 8 against the applicant in view of the manner in which they had conducted their case.

PATENTS ACT 1990

DECISION OF A DELEGATE OF THE COMMISSIONER OF PATENTS

Re:Patent Application No.776913 in the name of Arakis Ltd, opposition under section 59 of the Patents Act by Arakis Ltd, compliance with a notice requiring production of certain documents,…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Arakis Ltd v Media Pharma GmbH & Co KG and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2008] APO 34
Decision Date

CaseChat Overview and Summary

The case of Arakis Ltd v Media Pharma GmbH & Co KG involved a dispute over patent application 776913 for a dry powder composition comprising glycopyrrolate for the treatment of respiratory diseases. Media Pharma GmbH & Co KG (Meda Pharma) opposed the application and raised several issues during the proceedings, including a notice to produce documents, requests for extensions of time to serve evidence in reply, and a direction to defer the service of evidence in reply until certain matters were resolved. The delegate of the Commissioner of Patents, G A Jenkins, issued a decision on 16 December 2008. Jenkins found that Arakis had a lawful excuse for not complying with the notice to produce, as the documents sought were not relevant to the opposition proceedings. Jenkins granted Meda Pharma an extension of time to serve evidence in reply until 7 November 2008 but issued a direction to defer the service of evidence in reply for one month from the date of the decision. Jenkins also awarded costs against Arakis under schedule 8 due to their conduct during the proceedings.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.